メインコンテンツに移動

Industry expects fresh guidance on Mifid swaps transparency

Firms might need time to change their systems if Esma alters May 2017 guidance significantly

Tightrope lack of guidance
Seeking clarity: market participants are awaiting guidance from Esma on OTC derivatives, particularly on TOTV

Market participants expect the European Securities and Markets Authority to publish further guidance on the scope of over-the-counter derivatives subject to post-trade reporting requirements under new market rules in the European Union.

The expectation has been building ever since an Esma representative indicated the regulator would provide further information on how to determine if an instrument

コンテンツを印刷またはコピーできるのは、有料の購読契約を結んでいるユーザー、または法人購読契約の一員であるユーザーのみです。

これらのオプションやその他の購読特典を利用するには、info@risk.net にお問い合わせいただくか、こちらの購読オプションをご覧ください: http://subscriptions.risk.net/subscribe

現在、このコンテンツをコピーすることはできません。詳しくはinfo@risk.netまでお問い合わせください。

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Risk.net? View our subscription options

無料メンバーシップの内容をお知りになりたいですか?ここをクリック

パスワードを表示
パスワードを非表示にする

Most read articles loading...

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

ログイン
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here